|
NZ527917A
(en)
|
1999-11-12 |
2005-03-24 |
Biogen Inc |
Polycycoalkylpurines as adenosine receptor antagonists
|
|
EP1364659B1
(en)
|
2001-02-08 |
2009-11-11 |
Ono Pharmaceutical Co., Ltd. |
Remedies for urinary diseases comprising lpa receptor controlling agents
|
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
|
JP2013501064A
(ja)
|
2009-08-04 |
2013-01-10 |
アミラ ファーマシューティカルス,インコーポレーテッド |
リゾホスファチジン酸受容体アンタゴニストとしての化合物
|
|
GB2474748B
(en)
|
2009-10-01 |
2011-10-12 |
Amira Pharmaceuticals Inc |
Polycyclic compounds as lysophosphatidic acid receptor antagonists
|
|
GB2474120B
(en)
|
2009-10-01 |
2011-12-21 |
Amira Pharmaceuticals Inc |
Compounds as Lysophosphatidic acid receptor antagonists
|
|
TW201120016A
(en)
|
2009-12-08 |
2011-06-16 |
Abbott Lab |
Novel oxadiazole compounds
|
|
CN107721940A
(zh)
|
2010-12-07 |
2018-02-23 |
阿米拉制药公司 |
多环lpa1拮抗剂及其使用
|
|
WO2012078593A2
(en)
|
2010-12-07 |
2012-06-14 |
Amira Pharmaceuticals, Inc. |
Lysophosphatidic acid receptor antagonists and uses thereof
|
|
WO2012138648A1
(en)
|
2011-04-06 |
2012-10-11 |
Irm Llc |
Compositions and methods for modulating lpa receptors
|
|
WO2013070879A1
(en)
|
2011-11-10 |
2013-05-16 |
Bristol-Myers Squibb Company |
Methods for treating spinal cord injury with lpa receptor antagonists
|
|
MA37439B1
(fr)
|
2012-04-27 |
2017-02-28 |
Novartis Ag |
Inhibiteurs de dgat1 à ponts éthers cycliques pour le traitement de troubles medies par l'acyle coa-diacylglycerol transferase 1 (dgat1).
|
|
HK1206339A1
(en)
|
2012-06-20 |
2016-01-08 |
霍夫曼-拉罗奇有限公司 |
N-aryltriazole compounds as lpar antagonists
|
|
SG11201407220YA
(en)
|
2012-06-20 |
2014-12-30 |
Hoffmann La Roche |
N-alkyltriazole compounds as lpar antagonists
|
|
TW201437200A
(zh)
|
2013-01-15 |
2014-10-01 |
Intermune Inc |
溶血磷脂酸受體拮抗劑
|
|
US8962660B2
(en)
|
2013-03-14 |
2015-02-24 |
Bristol-Myers Squibb Company |
Oxabicyclo [2.2.2] acid GPR120 modulators
|
|
SG11201507459YA
(en)
|
2013-03-15 |
2015-10-29 |
Epigen Biosciences Inc |
Heterocyclic compounds useful in the treatment of disease
|
|
AR108838A1
(es)
*
|
2016-06-21 |
2018-10-03 |
Bristol Myers Squibb Co |
Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa
|
|
JP7202383B2
(ja)
|
2017-12-19 |
2023-01-11 |
ブリストル-マイヤーズ スクイブ カンパニー |
Lpaアンタゴニストとしてのピラゾールo-架橋カルバモイルシクロヘキシル酸
|
|
US11319309B2
(en)
|
2017-12-19 |
2022-05-03 |
Bristol-Myers Squibb Company |
Cyclohexyl acid isoxazole azines as LPA antagonists
|
|
JP7369125B2
(ja)
|
2017-12-19 |
2023-10-25 |
ブリストル-マイヤーズ スクイブ カンパニー |
Lpaアンタゴニストとしてのイソキサゾールo-架橋カルバモイルシクロヘキシル酸
|
|
PE20210655A1
(es)
|
2017-12-19 |
2021-03-31 |
Bristol Myers Squibb Co |
Carbamoil ciclohexil acidos ligados a n de triazol como antagonistas de lpa
|
|
KR102725744B1
(ko)
|
2017-12-19 |
2024-11-01 |
브리스톨-마이어스 스큅 컴퍼니 |
Lpa 길항제로서의 시클로헥실 산 피라졸 아진
|
|
ES2962367T3
(es)
|
2017-12-19 |
2024-03-18 |
Bristol Myers Squibb Co |
Acidos carbamoil ciclohexílicos N-enlazados a pirazol como antagonistas de receptores del ácido lisofosfatídico (LPA)
|
|
JP7212047B2
(ja)
|
2017-12-19 |
2023-01-24 |
ブリストル-マイヤーズ スクイブ カンパニー |
Lpaアンタゴニストとしてのシクロヘキシル酸ピラゾールアゾール
|
|
US11447475B2
(en)
|
2017-12-19 |
2022-09-20 |
Bristol-Myers Squibb Company |
Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
|
|
WO2019126087A1
(en)
|
2017-12-19 |
2019-06-27 |
Bristol-Myers Squibb Company |
Cyclohexyl acid isoxazole azoles as lpa antagonists
|
|
ES2946657T3
(es)
|
2018-09-18 |
2023-07-24 |
Bristol Myers Squibb Co |
Acidos ciclopentílicos como antagonistas de LPA
|
|
KR102800284B1
(ko)
|
2018-09-18 |
2025-04-23 |
브리스톨-마이어스 스큅 컴퍼니 |
Lpa 길항제로서의 시클로헵틸 산
|